New sedation approach may reduce breathing risks during ERCP
NCT ID NCT07166614
First seen Sep 30, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This study tested two sedatives—dexmedetomidine and propofol—in 100 high-risk patients undergoing ERCP, a procedure that requires deep sedation. The goal was to see which drug causes fewer breathing and heart-related side effects. Results could help doctors choose safer sedation for elderly or medically complex patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sisli etfal research and training hospital
Sarıyer, Istanbul, 34371, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.